Published in J Am Acad Dermatol on June 01, 2003
International guidelines for the in vivo assessment of skin properties in non-clinical settings: Part 2. transepidermal water loss and skin hydration. Skin Res Technol (2013) 0.87
Male Circumcision and HIV Transmission; What Do We Know? Open AIDS J (2014) 0.83
Self reported skin morbidity and ethnicity: a population-based study in a Western community. BMC Dermatol (2007) 0.83
Risk of squamous cell carcinoma of the skin in relation to IgE: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2011) 0.80
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol (2017) 0.77
Skin wrinkles and rigidity in early postmenopausal women vary by race/ethnicity: baseline characteristics of the skin ancillary study of the KEEPS trial. Fertil Steril (2010) 0.77
Assessment of skin conductance in African American and Non-African American participants in studies of conditioned fear. Psychophysiology (2017) 0.75
Understanding the Epidermal Barrier in Healthy and Compromised Skin: Clinically Relevant Information for the Dermatology Practitioner: Proceedings of an Expert Panel Roundtable Meeting. J Clin Aesthet Dermatol (2016) 0.75
The skin prick test - European standards. Clin Transl Allergy (2013) 1.60
Lifetime changes in the vulva and vagina. Arch Gynecol Obstet (2005) 1.25
Clinical microneedle injection of methyl nicotinate: stratum corneum penetration. Skin Res Technol (2005) 1.16
Immediate contact skin reactions, an update of Contact Urticaria, Contact Urticaria Syndrome and Protein Contact Dermatitis -- "A Never Ending Story". Eur J Dermatol (2010) 1.09
Exploration of "alternative" and "natural" drugs in dermatology. Arch Dermatol (2002) 1.08
Cutaneous allergic reactions to tattoo ink. J Cosmet Dermatol (2009) 1.06
Influence of usage practices, ethnicity and climate on the skin compatibility of sanitary pads. Arch Gynecol Obstet (2006) 0.95
Multifocal bilateral choroidal neovascularization in a patient on ipilimumab for metastatic melanoma. Cutan Ocul Toxicol (2013) 0.93
Cutaneous leukocytoclastic vasculitis due to erlotinib: just an adverse event or also a putative marker of drug efficacy? Cutan Ocul Toxicol (2013) 0.92
The Sino-American belt study: nickel and cobalt exposure, epidemiology, and clinical considerations. Dermatitis (2012) 0.86
Occlusion effect on in vivo percutaneous penetration of chemicals in man and monkey: partition coefficient effects. Skin Pharmacol Physiol (2013) 0.86
The correlation between transepidermal water loss and percutaneous absorption: an overview. J Control Release (2005) 0.82
Skin penetration flux and lag-time of steroids across hydrated and dehydrated human skin in vitro. Biol Pharm Bull (2006) 0.82
Sulfuric acid burns (corrosion and acute irritation): evidence-based overview to management. Cutan Ocul Toxicol (2006) 0.80
Percutaneous absorption of vapors in human skin. Cutan Ocul Toxicol (2010) 0.79
The possible relevance of sex hormones on irritant and allergic responses: their importance for skin testing. Contact Dermatitis (2009) 0.78
Stratum corneum evaluation methods: overview. Skin Res Technol (2013) 0.78
Skin friction blistering: computer model. Skin Res Technol (2007) 0.78
Metrics and clinical relevance of percutaneous penetration and lateral spreading. Skin Pharmacol Physiol (2014) 0.78
Dermatotoxicologic clinical solutions: hair dying in hair dye allergic patients? Cutan Ocul Toxicol (2014) 0.77
Multicenter Patch Testing With a Resol Resin Based on Phenol and Formaldehyde Within the International Contact Dermatitis Research Group. Dermatitis (2015) 0.77
Skin moisturization and frictional effects of an emollient-treated menstrual pad with a foam core. Cutan Ocul Toxicol (2009) 0.77
Contact allergy to common ingredients in hair dyes. Contact Dermatitis (2013) 0.77
Ex vivo calcium percutaneous eggression in normal and tape-stripped human skin. Cutan Ocul Toxicol (2011) 0.77
Topical absorption and systemic toxicity. Cutan Ocul Toxicol (2011) 0.77
Climate and skin function: an overview. Skin Res Technol (2013) 0.77
Pentane-1,5-diol as a percutaneous absorption enhancer. Arch Dermatol Res (2005) 0.77
Allergic contact dermatitis caused by palladium-containing dental implants. Dermatitis (2014) 0.77
Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects. Cutan Ocul Toxicol (2013) 0.76
In vitro human skin penetration of geraniol and citronellol. Dermatitis (2010) 0.76
Interindividual variation in transdermal and oral drug deliveries. J Pharm Sci (2012) 0.76
Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis. Expert Opin Drug Saf (2013) 0.76
Transungual delivery of ketoconazole using novel lacquer formulation. Int J Pharm (2013) 0.76
Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers. Drug Dev Ind Pharm (2013) 0.76
Human skin buffering capacity: an overview. Skin Res Technol (2008) 0.76
Drug dosage in the elderly: dermatological drugs. Drugs Aging (2006) 0.75
Photosensitivity: a current biological overview. Cutan Ocul Toxicol (2012) 0.75
Allergic contact dermatitis: effect of age. Cutan Ocul Toxicol (2011) 0.75
Contact dermatitis in agriculture. J Agromedicine (2007) 0.75
Cumulative skin irritation test of sanitary pads in sensitive skin and normal skin population. Cutan Ocul Toxicol (2007) 0.75
Wound-Related Allergic/Irritant Contact Dermatitis. Adv Skin Wound Care (2016) 0.75
In vitro skin decontamination model: comparison of salicylic acid and aminophylline. Cutan Ocul Toxicol (2014) 0.75
Dermatotoxicologic clinical solutions: textile dye dermatitis patch testing. Cutan Ocul Toxicol (2014) 0.75
Effects of soap-water wash on human epidermal penetration. J Appl Toxicol (2016) 0.75
Irritant contact dermatitis: effect of age. Cutan Ocul Toxicol (2011) 0.75
Do partition coefficients (liphophilicity/hydrophilicity) predict effects of occlusion on percutaneous penetration in vitro: a retrospective review. Cutan Ocul Toxicol (2013) 0.75
Occupational skin-care management. Int Arch Occup Environ Health (2003) 0.75
Pharmacogenomic biomarkers in dermatologic drugs. J Dermatolog Treat (2012) 0.75
Evidence or experience: that is the question. Am J Clin Dermatol (2014) 0.75
Dermatotoxicologic clinical solutions: clinical management of fragrance mix #1 #2 patients? Cutan Ocul Toxicol (2014) 0.75
Changing paradigms in dermatology: science and art of diagnostic patch and contact urticaria testing. Clin Dermatol (2003) 0.75
An overview of parabens and allergic contact dermatitis. Skin Therapy Lett (2013) 0.75
Pharmacogenomics in dermatology: Taking patient treatment to the next level. J Dermatolog Treat (2014) 0.75
Allergic contact dermatitis caused by farnesol: clinical relevance. Cutan Ocul Toxicol (2010) 0.75
Role of partition coefficients in determining the percutaneous penetration of salicylic acid and formaldehyde under varying occlusion durations. Drug Dev Ind Pharm (2013) 0.75